Literature DB >> 26114074

A Serendipitous Find: A Case of Cholangiocarcinoma Identified Incidentally After Acute Liver Injury Due to Cascara sagrada Ingestion.

Elizabeth S Nakasone1, Jinichi Tokeshi1.   

Abstract

The use of anthranoid laxatives such as Cascara sagrada can, in rare instances, produce a hepatitis that resolves with discontinuation of the offending supplement. However, the clinical presentation of abdominal pain, jaundice, clay-colored stools, and darkening urine can mimic the presentation of a variety of hepatobiliary illnesses, including cholangiocarcinoma. This case report describes a local patient diagnosed with an extrahepatic cholangiocarcinoma following workup for an acute hepatitis due to ingestion of large quantities of Cascara sagrada.

Entities:  

Keywords:  Drug-induced liver injury; cascara; cholangiocarcinoma; cholestasis; jaundice

Mesh:

Substances:

Year:  2015        PMID: 26114074      PMCID: PMC4477433     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  13 in total

1.  Senna-induced hepatitis in a poor metabolizer.

Authors:  Ulrich Seybold; Nikola Landauer; Susanne Hillebrand; Frank-Detlef Goebel
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

2.  Hepatitis after chronic abuse of senna.

Authors:  U Beuers; U Spengler; G R Pape
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

3.  Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity.

Authors:  A Nadir; D Reddy; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

Review 4.  Review article: anthranoid laxatives and their potential carcinogenic effects.

Authors:  B A van Gorkom; E G de Vries; A Karrenbeld; J H Kleibeuker
Journal:  Aliment Pharmacol Ther       Date:  1999-04       Impact factor: 8.171

5.  Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides.

Authors:  Bénédicte Vanderperren; Michela Rizzo; Luc Angenot; Vincent Haufroid; Michel Jadoul; Philippe Hantson
Journal:  Ann Pharmacother       Date:  2005-06-14       Impact factor: 3.154

6.  Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation.

Authors:  Alper Sonmez; M Ilker Yilmaz; Refik Mas; Ayhan Ozcan; Bülent Celasun; Teoman Dogru; Abdullah Taslipinar; I Hakki Kocar
Journal:  Acta Gastroenterol Belg       Date:  2005 Jul-Sep       Impact factor: 1.316

Review 7.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 8.  A review of the clinical diagnosis and therapy of cholangiocarcinoma.

Authors:  Denghua Yao; Vamsi Krishna Kunam; Xiao Li
Journal:  J Int Med Res       Date:  2013-12-23       Impact factor: 1.671

9.  [Toxic hepatitis following consumption of the herbal medicinal product Cascara Sagrada].

Authors:  Claire Jacobsen; Synne Semb; Hans Kromann-Andersen
Journal:  Ugeskr Laeger       Date:  2009-11-09

Review 10.  The metabolism of anthranoid laxatives.

Authors:  P de Witte; L Lemli
Journal:  Hepatogastroenterology       Date:  1990-12
View more
  1 in total

1.  Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.

Authors:  Yefeng Wang; Divya R Gunashekar; Terrence J Adam; Rui Zhang
Journal:  Stud Health Technol Inform       Date:  2017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.